Prevention of hyaline membrane disease with plasminogen. A cooperative study
- 25 April 1977
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 237 (17) , 1837-1841
- https://doi.org/10.1001/jama.237.17.1837
Abstract
In a double-blind, randomized study, 500 premature infants were treated with plasminogen or placebo i.v. within 60 min of birth. There was a substantial decrease in severe clinical respiratory distress, death caused by hyaline membrane disease, and total mortality in the plasminogen-treated infants as compared to the controls.This publication has 6 references indexed in Scilit:
- Pneumothorax in the Respiratory Distress Syndrome: Incidence and Effect on Vital Signs, Blood Gases, and pHPediatrics, 1976
- EPIDEMIOLOGY OF HYALINE-MEMBRANE DISEASE IN UNITED-STATES - ANALYSIS OF NATIONAL MORTALITY STATISTICS1976
- Transient Tachypnea of NewbornAmerican Journal of Diseases of Children, 1966
- Effect of surface active lipoprotein on clotting and fibrinolysis, and of fibrinogen on surface tension of surface active lipoproteinThe American Journal of Medicine, 1966
- Clinical pharmacology of various types of fibrinolytic enzyme preparationsThe American Journal of Cardiology, 1960
- ON PLASMA FIBRINOLYTIC ACTIVITY INDUCED BY ISCHAEMIA1956